UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes

Journal of gastroenterology, 2014-11, Vol.49 (11), p.1504-1513

2014

Volltextzugriff (PDF)

Considerations and Regulatory Challenges for Innovative Medicines in Expedited Approval Programs: Breakthrough Therapy and Sakigake Designation

Therapeutic innovation & regulatory science, 2020-07, Vol.54 (4), p.814-820

2020

Volltextzugriff (PDF)

Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity

Nature communications, 2016-10, Vol.7 (1), p.12977-12977, Article 12977

2016

Volltextzugriff (PDF)

TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass

Diabetologia, 2014-03, Vol.57 (3), p.542-553

2014

Volltextzugriff (PDF)

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

Hepatology research, 2019-06, Vol.49 (6), p.617-626

2019

Volltextzugriff (PDF)

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Journal of gastroenterology, 2017-07, Vol.52 (7), p.845-854

2017

Volltextzugriff (PDF)

Impact of Quality by Design Development on the Review Period of New Drug Approval and Product Quality in Japan

Therapeutic innovation & regulatory science, 2020-09, Vol.54 (5), p.1192-1198

2020

Volltextzugriff (PDF)

Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence Studies

Therapeutic innovation & regulatory science, 2021-09, Vol.55 (5), p.1096-1100

2021

Volltextzugriff (PDF)

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

Hepatology research, 2020-02, Vol.50 (2), p.174-181

2020

Volltextzugriff (PDF)

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy

Journal of hepatology, 2013-10, Vol.59 (4), p.667-674

2013

Volltextzugriff (PDF)

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

Hepatology research, 2017-03, Vol.47 (3), p.E120-E131

2017

Volltextzugriff (PDF)

Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

Hepatology international, 2022-04, Vol.16 (2), p.282-293

2022

Volltextzugriff (PDF)

Sodium Alginate Inhibits Methotrexate-Induced Gastrointestinal Mucositis in Rats

Biological and Pharmaceutical Bulletin, 2013/10/01, Vol.36(10), pp.1528-1534

2013

Volltextzugriff (PDF)

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study

Journal of gastroenterology, 2013-03, Vol.48 (3), p.382-390

2013

Volltextzugriff (PDF)

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C

Cancers, 2020-09, Vol.12 (9), p.2602

2020

Volltextzugriff (PDF)

Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C

Journal of gastroenterology and hepatology, 2015-08, Vol.30 (8), p.1309-1316

2015

Volltextzugriff (PDF)

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan

BMJ open, 2019-06, Vol.9 (6), p.e023405-e023405

2019

Volltextzugriff (PDF)

Effectiveness of biweekly low-dosage peginterferon treatment on the improvement of serum alanine aminotransferase and α-fetoprotein levels

Hepatology research, 2012-03, Vol.42 (3), p.254-263

2012

Volltextzugriff (PDF)

Persistence of Viremia and Production of Neutralizing Antibodies Differentially Regulated by Polymorphic APOBEC3 and BAFF-R Loci in Friend Virus-Infected Mice

Journal of Virology, 2010-06, Vol.84 (12), p.6082-6095

2010

Volltextzugriff (PDF)

Infection of adult thymus with murine retrovirus induces virus-specific central tolerance that prevents functional memory CD8+ T cell differentiation

PLoS pathogens, 2014-03, Vol.10 (3), p.e1003937-e1003937

2014

Volltextzugriff (PDF)

Significance of hepatic resection for hepatocellular carcinoma with sustained virological response to interferon therapy for chronic hepatitis C

Hepatology research, 2013-06, Vol.43 (6), p.605-609

2013

Volltextzugriff (PDF)

Hepatitis B caused by a hepatitis B surface antigen escape mutant

Journal of gastroenterology, 2008-03, Vol.43 (3), p.243-247

2008

Volltextzugriff (PDF)

Bacterial Infection as an Adverse Effect of Telaprevir-based Triple Therapy for Chronic Hepatitis C Infection

Internal Medicine, 2015, Vol.54(6), pp.567-572

2015

Volltextzugriff (PDF)

Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection

Antiviral research, 2014-04, Vol.104, p.102-109

2014

Volltextzugriff (PDF)

Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C

Hepatology research, 2016-03, Vol.46 (3), p.E174-E180

2016

Volltextzugriff (PDF)

1 – 25 von 352

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(290)

Publikationsform

Sprache

Englisch
(284)
Japanisch
(99)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes

Considerations and Regulatory Challenges for Innovative Medicines in Expedited Approval Programs: Breakthrough Therapy and Sakigake Designation

Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity

TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Impact of Quality by Design Development on the Review Period of New Drug Approval and Product Quality in Japan

Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence Studies

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

Sodium Alginate Inhibits Methotrexate-Induced Gastrointestinal Mucositis in Rats

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C

Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan

Effectiveness of biweekly low-dosage peginterferon treatment on the improvement of serum alanine aminotransferase and α-fetoprotein levels

Persistence of Viremia and Production of Neutralizing Antibodies Differentially Regulated by Polymorphic APOBEC3 and BAFF-R Loci in Friend Virus-Infected Mice

Infection of adult thymus with murine retrovirus induces virus-specific central tolerance that prevents functional memory CD8+ T cell differentiation

Significance of hepatic resection for hepatocellular carcinoma with sustained virological response to interferon therapy for chronic hepatitis C

Hepatitis B caused by a hepatitis B surface antigen escape mutant

Bacterial Infection as an Adverse Effect of Telaprevir-based Triple Therapy for Chronic Hepatitis C Infection

Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection

Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C

Suchergebnisse filtern